Extrapulmonary clinical manifestations in COVID-19 patients A Sarkesh, AD Sorkhabi, E Sheykhsaran, F Alinezhad, ... The American journal of tropical medicine and hygiene 103 (5), 1783, 2020 | 103 | 2020 |
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies AD Sorkhabi, LM Khosroshahi, A Sarkesh, A Mardi, A Aghebati-Maleki, ... Frontiers in Immunology, 2023 | 49 | 2023 |
The regulatory role of autophagy-related miRNAs in lung cancer drug resistance M Shahverdi, K Hajiasgharzadeh, AD Sorkhabi, M Jafarlou, M Shojaee, ... Biomedicine & Pharmacotherapy 148, 112735, 2022 | 32 | 2022 |
Allogeneic lymphocytes immunotherapy in female infertility: lessons learned and the road ahead A Sarkesh, AD Sorkhabi, H Ahmadi, S Abdolmohammadi-Vahid, ... Life Sciences 299, 120503, 2022 | 15 | 2022 |
Cancer combination therapies by silencing of CTLA-4, PD-L1, and TIM3 in osteosarcoma AD Sorkhabi, A Sarkesh, A Fotouhi, H Saeedi, L Aghebati-Maleki IUBMB life, 2022 | 12 | 2022 |
The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme A Daei Sorkhabi, A Sarkesh, F Marofi, M Ghaebi, N Silvestris, ... Frontiers in Oncology, 1638, 2022 | 12 | 2022 |
Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility A Daei Sorkhabi, A Sarkesh, A Daei Sorkhabi, T Entezari-Maleki, ... Journal of Basic and Clinical Physiology and Pharmacology 33 (1), 55-77, 2020 | 12 | 2020 |
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis N Shomali, B Baradaran, AD Sorkhabi, A Sarkesh, MS Kahrizi, F Tosan, ... Gene 844, 146829, 2022 | 8 | 2022 |
The immunomodulatory effect of intradermal allogeneic PBMC therapy in patients with recurrent spontaneous abortion A Sarkesh, AD Sorkhabi, F Parhizkar, MS Soltani-Zangbar, M Yousefi, ... Journal of Reproductive Immunology 156, 103818, 2023 | 6 | 2023 |
Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin S Noorolyai, E Baghbani, S Mahboob, F Zargari, A Sorkhabi, P Sameti, ... Pathology-Research and Practice 240, 154194, 2022 | 5 | 2022 |
A systematic review of the safety and efficacy of monoclonal antibodies for progressive multiple sclerosis Z Sabahi, AD Sorkhabi, A Sarkesh, A Naseri, N Asghar-Rezaei, M Talebi International Immunopharmacology 120, 110266, 2023 | 4 | 2023 |
The efficacy of hemiepiphysiodesis for idiopathic knee coronal angular deformity by reconstruction plate and screw: A pilot study A Maleki, M Qoreishi, A Bisadi, F Safdari, A Daei Sorkhabi, A Fotouhi, ... Health Science Reports 6 (6), e1302, 2023 | 2 | 2023 |
The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials A Daei Sorkhabi, M ZareDini, A Fazlollahi, A Sarkesh, A Naseri, ... BMC Pulmonary Medicine 23 (1), 495, 2023 | 1 | 2023 |
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice A Daei Sorkhabi, E Komijani, A Sarkesh, P Ghaderi Shadbad, ... Cell Communication and Signaling 21 (1), 321, 2023 | 1 | 2023 |
Radiological features of late-onset multiple sclerosis: A systematic review and meta-analysis E Nasiri, A Sarkesh, AD Sorkhabi, A Naseri, S Daneshvar, AN Moghadasi, ... Journal of Neuroradiology, 2023 | 1 | 2023 |
Diagnostic value of an increase in central venous pressure during SBT for prediction of weaning failure in mechanically ventilated patients: A cross‐sectional study AA Ghamari, K Amini, A Daei Sorkhabi, A Sarkesh, SH Saghaleini, ... Health Science Reports 6 (4), e1204, 2023 | 1 | 2023 |
Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis E Sadeghi Hokmabadi, A Daei Sorkhabi, A Sarkesh, S Sadigh-Eteghad, ... Acta Neurologica Belgica, 1-8, 2024 | | 2024 |
Viruses and thrombocytopenia R Rasizadeh, F Ebrahimi, A Zamani, AD Sorkhabi, A Sarkesh, JS Nahand, ... Heliyon, 2024 | | 2024 |
Restoration of miR-200c sensitizes breast cancer cells to cytarabine MM Moghaddam, E Baghbani, H Alizadeh, B Najafzadeh, T Kazemi, ... | | 2023 |
Efficacy and safety of veliparib plus chemotherapy for the treatment of lung cancer: A systematic review of clinical trials A Daei Sorkhabi, A Fazlollahi, A Sarkesh, R Aletaha, H Feizi, SE Mousavi, ... Plos one 18 (9), e0291044, 2023 | | 2023 |